FDA Approved: * March 30, 2020
Pharm Company: * STRIDES PHARMA
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Roflumilast Overview

Roflumilast, sold under the trade name Daxas among others, is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD).[6][7][8][9] In June 2010, it was approved in the European Union for severe COPD assoc...

Read more Roflumilast Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Roflumilast Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 250mcg, 500mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Roflumilast: (1 result)

Sorted by National Drug Code
  • 13668-476 Roflumilast 500 ug/1 Oral Tablet by Torrent Pharmaceuticals Limited

Other drugs which contain Roflumilast or a similar ingredient: (1 result)

Related Roflumilast Topics:

in what way roflumilast is benifitial as compared to the existing ## As compared to the existing what? Please be more sp... 1 reply